Anemoside A3
CAS No. 129724-84-1
Anemoside A3( —— )
Catalog No. M17927 CAS No. 129724-84-1
Anemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 60 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 141 | In Stock |
|
| 50MG | 207 | In Stock |
|
| 100MG | 304 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnemoside A3
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
-
DescriptionAnemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number129724-84-1
-
Formula Weight750.96
-
Molecular FormulaC41H66O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (66.58 mM)
-
SMILES[C@H]12[C@@](CC[C@]3([C@@]4(CC[C@H]5[C@]([C@H](CC[C@@]5([C@H]4CC[C@H]13)C)O[C@@H]1OC[C@@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)(C)CO)C)C)(CC[C@H]2C(=C)C)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ip FC, Fu WY, Cheng EY, Tong EP, et al.Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection.Neuropsychopharmacology. 2015 Jul;40(8):1877-87.
molnova catalog
related products
-
VEGFR-2-IN-9
VEGFR-2-IN-9 (KDR-in-4) is a potent KDR/VEGFR2 inhibitor with an IC50 of 7 nM, suitable for breast cancer research.
-
DMH4
DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
-
Cediranib
A highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.
Cart
sales@molnova.com